Review paper

Antibody–Drug Conjugates for Cancer Treatment

Volume: 69, Issue: 1, Pages: 191 - 207
Published: Jan 29, 2018
Abstract
The concept of exploiting the specific binding properties of monoclonal antibodies as a mechanism for selective delivery of cytotoxic agents to tumor cells is an attractive solution to the challenge of increasing the therapeutic index of cell-killing agents for treating cancer. All three parts of an antibody-drug conjugate (ADC)-the antibody, the cytotoxic payload, and the linker chemistry that joins them together-as well as the biologic...
Paper Details
Title
Antibody–Drug Conjugates for Cancer Treatment
Published Date
Jan 29, 2018
Volume
69
Issue
1
Pages
191 - 207
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.